Jun Yan
Director/Board Member at JIANGSU SHENTONG VALVE CO., LTD.
Jun Yan active positions
Companies | Position | Start | End |
---|---|---|---|
JIANGSU SHENTONG VALVE CO., LTD. | Director/Board Member | 25/07/2019 | - |
Independent Dir/Board Member | 25/07/2019 | - | |
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. | Director/Board Member | 28/11/2019 | - |
Independent Dir/Board Member | 28/11/2019 | - | |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Director/Board Member | 08/09/2020 | - |
Independent Dir/Board Member | 08/09/2020 | - |
Career history of Jun Yan
Former positions of Jun Yan
Companies | Position | Start | End |
---|---|---|---|
WENFENG GREAT WORLD CHAIN DEVELOPMENT CORPORATION | Director/Board Member | 22/09/2017 | - |
Independent Dir/Board Member | 22/09/2017 | - |
Training of Jun Yan
Fudan University | Undergraduate Degree |
Statistics
International
China | 6 |
Operational
Director/Board Member | 4 |
Independent Dir/Board Member | 4 |
Undergraduate Degree | 1 |
Sectoral
Retail Trade | 2 |
Producer Manufacturing | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
WENFENG GREAT WORLD CHAIN DEVELOPMENT CORPORATION | Retail Trade |
JIANGSU SHENTONG VALVE CO., LTD. | Producer Manufacturing |
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
- Stock Market
- Insiders
- Jun Yan
- Experience